Global Financial Private Client, LLC Biogen Inc. Transaction History
Global Financial Private Client, LLC
- $239 Billion
- Q2 2024
A detailed history of Global Financial Private Client, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 90 shares of BIIB stock, worth $18,298. This represents 0.01% of its overall portfolio holdings.
Number of Shares
90
Previous 90
-0.0%
Holding current value
$18,298
Previous $19.3 Million
7.91%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding BIIB
# of Institutions
1,049Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.38 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.32 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.96 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.44 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.15 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $29.3B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...